TOXICOLOGY AND CARCINOGENESIS STUDIES OF CUMENE (CAS NO. 98-82-8) IN F344/N RATS AND B6C3F1 MICE (INHALATION STUDIES)

NTP Technical Report on the Toxicology and Carcinogenesis Studies Series

Volumn TR-542, Issue , 2009, Pages 1-206

  Chan, P C ^a,e   Peckham, J C ^a,c,e   Bristol, D W ^a   Bucher, J R ^a   Burka, L T ^a   Chhabra, R S ^a   Herbert, R A ^a,e   King Herbert, A P ^a   Kissling, G E ^a   Malarkey, D E ^a,e   Peddada, S D ^a   Roycroft, J H ^a   Sanders, J M ^a   Smith, C S ^a   Travlos, G S ^a   Waidyanatha, S ^a   Witt, K L ^a   Dill, J A ^b   Grumbein, S L ^b   Hayden, B K ^b   Renne, R A ^b   Hamlin, M H ^c   Cimon, K J ^c,e   Brecher, S ^d   Suttie, A W ^e   Cesta, M F ^e   Dick, E ^e   Elmore, S A ^e   Hard, G C ^e   Little, P B ^e   Pearse, G ^e   Sills, R C ^e   Hanes, M A ^e   Flake, G P ^e   Yoshizawa, K ^e   Crockett, P W ^f   Betz, L J ^f   McGowan, K P ^f   Gunnels, S R ^g   Harper, L M ^g   Serbus, D C ^g   Simmons, G E ^g   more..

^a National Toxicology Program

^b BATTELLE MEMORIAL INSTITUTE   (United States)

^c EXPERIMENTAL PATHOLOGY LABORATORIES INC   (United States)

^d DYNAMAC CORPORATION   (United States)

^e NTP Pathology Working Group

^f Constella Group Inc ^*

^g Biotechnical Services Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957942166     PISSN: 23788917     EISSN: 23788925     Source Type: Book Series    
DOI: None     Document Type: Review

References (143)

1. 1H FT-NMR Spectra (1993). 1st ed. (C.J. Pouchert and J. Behnke, Eds.), Vol. 2, p. 2B. Aldrich Chemical Company, Inc., Milwaukee, WI.
2. The Aldrich Library of FT-IR Spectra (1997). 2nd ed. (C.J. Pouchert, Ed.), Vol. 2, p. 1627A. Sigma-Aldrich Company, Milwaukee, WI.
3. American Conference of Governmental Industrial Hygienists (ACGIH) (1993). Documentation of the Threshold Limit Values and Biological Exposure Indices, 6th ed., pp. 346-347. Cincinnati, OH.
4. ® Based on the Documentation of the Threshold Limit Values for Chemical Substances and Physical Agents & Biological Exposure Indices, p. 22. Cincinnati, OH.
5. Andrews, L.S., and Snyder, R. (1993). Toxic effects of solvents and vapors. In Casarett and Doull’s Toxicology, 4th ed. (M.O. Amdu, J. Doull, and C.D. Klaassen, Eds.), pp. 681-722. Pergamon Press, New York.
6. Anonymous (1993). Chemical profile: Cumene. Chem. Mark. Rep. 244, p. 49.
7. Anonymous (1995). Facts and figures for the chemical industry. Chem. Eng. News 73, pp. 39-40.
8. Ashby, J., and Tennant, R.W. (1991). Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257, 229-306.
9. Bailer, A.J., and Portier, C.J. (1988). Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics 44, 417-431.
10. Bieler, G.S., and Williams, R.L. (1993). Ratio estimates, the delta method, and quantal response tests for increased carcinogenicity. Biometrics 49, 793-801.
11. Boogaard, P.J., de Kloe, K.P., Sumner, S.C., van Elburg, P.A., and Wong, B.A. (2000). Disposition of [ring-U-(14)C]styrene in rats and mice exposed by recirculating nose-only inhalation. Toxicol. Sci. 58, 161-172.
12. Boorman, G.A., Montgomery, C.A., Jr., Eustis, S.L., Wolfe, M.J., McConnell, E.E., and Hardisty, J.F. (1985). Quality assurance in pathology for rodent carcinogenicity studies. In Handbook of Carcinogen Testing (H.A. Milman and E.K. Weisburger, Eds.), pp. 345-357. Noyes Publications, Park Ridge, NJ.
13. Boorman, G.A., Morgan, K.T., and Uriah, L.C. (1990). Nose, larynx, and trachea. In Pathology of the Fischer Rat. Reference and Atlas (G.A. Boorman, S.L. Eustis, M.R. Elwell, C.A. Montgomery, Jr., and W.F. MacKenzie, Eds.), pp. 315-337. Academic Press, Inc., San Diego.
14. Brecher, G., and Schneiderman, M. (1950). A time-saving device for the counting of reticulocytes. Am. J. Clin. Pathol. 20, 1079-1083.
15. Brown, H.R., Monticello, T.M., Maronpot, R.R., Randall, H.W., Hotchkiss, J.R., and Morgan, K.T. (1991). Proliferative and neoplastic lesions in the rodent nasal cavity. Toxicol. Pathol. 19, 358-372.
16. Buckpitt, A., Chang, A.M., Weir, A., Van Winkle, L., Duan, X., Philpot, R., and Plopper, C.(1995). Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters. Mol. Pharmacol. 47, 74-81.
17. Cavender, F. (1994). Aromatic hydrocarbons. In Patty’s Industrial Hygiene and Toxicology, 4th ed. (G.D. Clayton and F.E. Clayton, Eds.), Vol. II, pp. 1304-1305, 1346-1349. John Wiley & Sons, Inc., New York.
18. Chan, P.C., Haseman, J.K., Mahler, J., and Aranyi, C. (1998). Tumor induction in F344/N rats and B6C3F1 mice following inhalation exposure to ethylbenzene. Toxicol. Lett. 99, 23-32.
19. Code of Federal Regulations (CFR) 21, Part 58.
20. Code of Federal Regulations (CFR) 29, Part 1910.1000.
21. Cox, D.R. (1972). Regression models and life-tables. J. R. Stat. Soc. B34, 187-220.
22. Crawford, B.D. (1985). Perspectives on the somatic mutation model of carcinogenesis. In Advances in Modern Environmental Toxicology. Mechanisms and Toxicity of Chemical Carcinogens and Mutagens (M.A. Mehlman, W.G. Flamm, and R.J. Lorentzen, Eds.), pp. 13-59. Princeton Scientific Publishing Company, Inc., Princeton, NJ.
23. Cruzan, G., Carlson, G.P., Johnson, K.A., Andrews, L.S., Banton, M.I., Bevan, C., and Cushman, J.R. (2002). Styrene respiratory tract toxicity and mouse lung tumors are mediated by CYP2F-generated metabolites. Regul. Toxicol. Pharmacol. 35, 308-319.
24. Curren, R.D. (1987). Unscheduled DNA Synthesis in Rat Primary Hepatocytes (Laboratory Study No. T4786.380005; EPA OTS Fiche No. 0522853). Microbiological Associates, Inc., Bethesda, MD.
25. Cushman, J.R., Norris, J.C., Dodd, D.E., Darmer, K.I., and Morris, C.R. (1995). Subchronic inhalation toxicity and neurotoxicity assessment of cumene in Fisher 344 rats. J. Am. Coll. Toxicol. 14, 129-147.
26. Dixon, D., Herbert, R.A., Sills, R.C., and Boorman, G.A. (1999). Lungs, pleura, and mediastinum. In Pathology of the Mouse (R.R. Maronpot, G.A. Boorman, and B.W. Gaul, Eds.), pp. 293-332. Cache River Press, Vienna, IL.
27. Dixon, W.J., and Massey, F.J., Jr. (1957). Introduction to Statistical Analysis, 2nd ed., pp. 276-278, 412. McGraw-Hill Book Company, Inc., New York.
28. Dunn, O.J. (1964). Multiple comparisons using rank sums. Technometrics 6, 241-252.
29. Dunnett, C.W. (1955). A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 50, 1096-1121.
30. Fabre, R., Truhaut, R., Bernuchon, J., and Loisillier, F. (1955). Toxicologic research on solvents replacing benzene. III. Study of isopropylbenzene or cumene [in French]. Arch. Mal. Prof. 16, 285-299.
31. Florin, I., Rutberg. L., Curvall, M., and Enzell, C.R. (1980). Screening of tobacco smoke constituents for mutagenicity using the Ames’ test. Toxicology 15, 219-232.
32. Foley, J.F., Anderson, M.W., Stoner, G.D., Gaul, B.W., Hardisty, J.F., and Maronpot, R.R. (1991). Proliferative lesions of the mouse lung: Progression studies in strain A mice. Exp. Lung Res. 17, 157-168.
33. Goldstein, R.S., and Schnellmann, R.G. (1996). Toxic responses of the kidney. In Casarett and Doull’s Toxicology The Basic Science of Poisons, 5th ed. (C.D. Klaassen, Ed.), Chapter 14. McGraw-Hill Medical Publishing Company, New York.
34. Gosselin, R.E., Smith, R.P., Hodge, H.C., and Braddock, J. (1984). Clinical Toxicology of Commercial Products, 5th ed., pp. II-151. Williams & Wilkins, Baltimore, MD.
35. Gulf Life Sciences Center (GLSC) (1985a). CHO/HGPRT Test of Cumene (Project No. 84-2128; EPA OTS Fiche No. 0206775). Gulf Life Sciences Center, Pittsburgh, PA.
36. GulfLifeSciencesCenter(GLSC)(1985b). Micronucleus Test of Cumene (Project No. 84-2129; EPA OTS Fiche No. 0522838). Gulf Life Sciences Center, Pittsburgh, PA.
37. Hard, G.C., Rodgers, I.S., Baetcke, K.P., Richards, W.L., McGaughy, R.E., and Valcovic, L.R. (1993). Hazard evaluation of chemicals that cause accumulation of alpha 2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats. Environ. Health Perspect. 99, 313-349.
38. Hawley’s Condensed Chemical Dictionary (1993). 12th ed. (R.J. Lewis, Sr., Ed.), pp. 328-329. Van Nostrand Reinhold, New York.
39. Hazardous Substances Data Bank (HSDB) (2003). National Institute for Occupational Safety and Health, HSDB database available through the National Library of Medicine MEDLARS System.
40. Heddle, J.A., Hite, M., Kirkhart, B., Mavournin, K., MacGregor, J.T., Newell, G.W., and Salamone, M.F. (1983). The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat. Res. 123, 61-118.
41. Hollander, M., and Wolfe, D.A. (1973). Nonparametric Statistical Methods, pp. 120-123. John Wiley and Sons, New York.
42. Integrated Laboratory Systems (ILS) (1990). Micronucleus Data Management and Statistical Analysis Software, Version 1.4. ILS, Inc., P.O. Box 13501, Research Triangle Park, NC 27707.
43. Ishida, T., and Matsumoto, T. (1992). Enantioselective metabolism of cumene. Xenobiotica 22, 1291-1298.
44. Jackson, J. (1985). Test Rule Support Document Cumene, p. 170. SRC-TR-85-098. Syracuse Research Corporation, Syracuse, NY.
45. Jenkins, L.J., Jr., Jones, R.A., and Siegel, J. (1970). Long-term inhalation screening studies of benzene, toluene, o-xylene, and cumene on experimental animals. Toxicol. Appl. Pharmacol. 16, 818-823.
46. Jonckheere, A.R. (1954). A distribution-free k-sample test against ordered alternatives. Biometrika 41, 133-145.
47. Kaplan, E.L., and Meier, P. (1958). Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457-481.
48. Kirschner, E.M. (1996). Growth of top 50 chemicals slowed in 1995 from very high 1994 rate. Chem. Eng. News 74, 16-20.
49. Kohn, M.C., and Melnick, R.L. (1999). A physiological model for ligand-induced accumulation of alpha 2u globulin in male rat kidney: Roles of protein synthesis and lysosomal degradation in the renal dosimetry of 2,4,4-trimethyl-2-pentanol. Toxicology 136, 89-105.
50. Lee, E.W. (1987). Cumene. In Ethel Browning’s Toxicity and Metabolism of Industrial Solvents, 2nd ed. (R. Snyder, Ed.), Vol. 1, Hydrocarbons, Section 1.5. Elsevier Science Publishers, New York.
51. Lehman-McKeeman, L.D. (1997). Alpha 2u-globu-lin nephropathy. In Comprehensive Toxicology (R.S. Goldstein, Ed.), Vol. 7, pp. 677-692. Elsevier, Oxford, England.
52. Lide, D.R., Ed. (1995). CRC Handbook of Chemistry and Physics, 76th ed., pp. 3-55. CRC Press, Inc., Boca Raton, FL.
53. McConnell, E.E., Solleveld, H.A., Swenberg, J.A., and Boorman, G.A. (1986). Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. JNCI 76, 283-289.
54. McGregor, D.B., Brown, A., Cattanach, P., Edwards, I., McBride, D., Riach, C., and Caspary, W.J. (1988). Responses of the L5178Y tk+/tkmouse lymphoma cell forward mutation assay: III. 72 coded chemicals. Environ. Mol. Mutagen. 12, 85-154.
55. MacGregor, J.T., Wehr, C.M., Henika, P.R., and Shelby, M.D. (1990). The in vivo erythrocyte micronucleus test: Measurement at steady state increases assay efficiency and permits integration with toxicity studies. Fundam. Appl. Toxicol. 14, 513-522.
56. Maltoni, C., Conti, B., Cotti, G., and Belpoggi, F. (1985). Experimental studies on benzene carcinogenicity at the Bologna Institute of Oncology: Current results and ongoing research. Am. J. Ind. Med. 7, 415-446.
57. Mannsville Chemical Products Corporation (1985). Chemical Products Synopsis: Cumene, p. 1. Mannsville Chemical Products Corporation, Cortland, NY.
58. Maronpot, R.R., and Boorman, G.A. (1982). Interpretation of rodent hepatocellular proliferative alterations and hepatocellular tumors in chemical safety assessment. Toxicol. Pathol. 10, 71-80.
59. Melnick, R.L. (1992). An alternative hypothesis on the role of chemically induced protein droplet (alpha 2u-globulin) nephropathy in renal carcinogenesis. Reg. Toxicol. Pharmacol. 16, 111-125.
60. The Merck Index (1989). 11th ed. (S. Budavari, Ed.), p. 410. Merck and Company, Rahway, NJ.
61. Miller, J.A., and Miller, E.C. (1977). Ultimate chemical carcinogens as reactive mutagenic electrophiles. In Origins of Human Cancer (H.H. Hiatt, J.D. Watson, and J.A. Winsten, Eds.), pp. 605-627. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
62. Montgomery, C.A., Jr., and Seely, J.C. (1990). Kidney. In Pathology of the Fischer Rat. (G.A. Boorman, S.L. Eustis, M.R. Elwell, C.A. Montgomery, Jr., and W.F. MacKenzie, Eds.), pp. 127-153. Academic Press, Inc., San Diego.
63. Morgan, K.T., and Harkema, J.R. (1996). The upper respiratory system. Neoplasms: nasal neoplasia. In Monographs on Pathology of Laboratory Animals: Respiratory System (T.C. Jones, D.L. Dungworth, and U. Mohr, Eds.), pp. 87-104. Springer Verlag, New York.
64. Morrison, D.F. (1976). Multivariate Statistical Methods, 2nd ed., pp. 170-179. McGraw-Hill Book Company, New York.
65. National Institute for Occupational Safety and Health (NIOSH) (2005). NIOSH pocket guide to chemical hazards, p. 81. U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Washington, DC.
66. National Institute for Occupational Safety and Health/Occupational Safety and Health Administration (NIOSH/OSHA) (1981). Occupational health guidelines for chemical hazards. DHHS Publication No. 81-123. U.S. Department of Health and Human Services and U.S. Department of Labor, Washington, DC.
67. National Research Council (NRC) (1981). The Alkyl Benzenes, pp. 237-238. Committee on Alkyl Benzene Derivatives, Board on Toxicology and Environmental Health Hazards, Assembly of Life Sciences. National Academy Press, Washington, DC.
68. 1 Mice (Inhalation Studies). Technical Report Series No. 466. NIH Publication No. 99-3956. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC.
69. 1 Mice (Inhalation Studies). Technical Report Series No. 543. NIH Publication No. 08-4474. National Institutes of Health, Public Health Service, U.S. Department of Health and Human Services, Research Triangle Park, NC.
70. Neeper-Bradley, T.L. (1989a). Developmental Toxicity Study of Inhaled Cumene Vapor in CD (Sprague-Dawley) Rats (Project Report 52-621; EPA OTS Fiche No. 0522881; see fiche 7 of 18). Bushy Run Research Center, Export, PA.
71. Neeper-Bradley, T.L. (1989b). Developmental Toxicity Study of Inhaled Cumene Vapor in New Zealand White Rabbits (Project Report 52-622; EPA OTS Fiche No. 0522881; see fiche 10 of 18). Bushy Run Research Center, Export, PA.
72. NIST/EPA/NIH Mass Spectral Database (1994). Standard Reference Database 1A. Standard Reference Data Program. National Institute of Standards and Technology. U.S. Department of Commerce, Gaithersburg, MD.
73. Parmeggiani, E., Ed. (1983). Encyclopedia of Occupational Health and Safety, 3rd ed. (revised), pp. 572-573. International Labour Office, Geneva, Switzerland.
74. Piegorsch, W.W., and Bailer, A.J. (1997). Statistics for Environmental Biology and Toxicology, Section 6.3.2. Chapman and Hall, London.
75. Portier, C.J., and Bailer, A.J. (1989). Testing for increased carcinogenicity using a survival-adjusted quantal response test. Fundam. Appl. Toxicol. 12, 731-737.
76. Portier, C.J., Hedges, J.C., and Hoel, D.G. (1986). Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program’s carcinogenicity experiments. Cancer Res. 46, 4372-4378.
77. Putman, D.L. (1987). Chromosome Aberrations in Chinese Hamster Ovary (CHO) Cells (Laboratory Study No. T4786.337012; EPA OTS Fiche No. 0522852). Microbiological Associates, Inc., Bethesda, MD.
78. Rao, G.N. (1996). New diet (NTP-2000) for rats in the National Toxicology Program toxicity and carcinogenicity studies. Fundam. Appl. Toxicol. 32, 102-108.
79. Rao, G.N. (1997). New nonpurified diet (NTP-2000) for rodents in the National Toxicology Program’s toxicology and carcinogenesis studies. J. Nutr. 127, 842s-846s.
80. Sato, A., and Nakajima, T. (1987). Pharmacokinetics of organic solvent vapors in relation to their toxicity. Scand. J. Work Environ. Health. 13, 81-93.
81. Schmid, W. (1975). The micronucleus test. Mutat. Res. 31, 9-15.
82. Schnellmann, R.G. (2001). Toxic responses of the kidney. In Casarett and Doull’s Toxicology The Basic Science of Poisons, 6th ed. (C.D. Klaassen, Ed.), Chapter 14. McGraw-Hill Medical Publishing Company, New York.
83. Schulz, R.C., Van Opdorp, P.J., and Ward, D.J. (1993). Cumene. In Kirk-Othmer Encyclopedia of Chemical Technology, 4th ed. (J.I. Kroschwitz and M. Howe-Grant, Eds.), Vol. 7, pp. 730-736. John Wiley & Sons, Inc., New York.
84. Senczuk, W., and Litewka, B. (1976). Absorption of cumene through the respiratory tract and excretion of dimethylphenylcarbinol in urine. Br. J. Ind. Med. 33, 100-105.
85. Shelby, M.D. (1988). The genetic toxicity of human carcinogens and its implications. Mutat. Res. 204, 3-15.
86. Shelby, M.D., and Witt, K.L. (1995). Comparison of results from mouse bone marrow chromosome aberration and micronucleus tests. Environ. Mol. Mutagen. 25, 302-313.
87. Shelby, M.D., and Zeiger, E. (1990). Activity of human carcinogens in the Salmonella and rodent bone-marrow cytogenetics tests. Mutat. Res. 234, 257-261.
88. Shelby, M.D., Erexson, G.L., Hook, G.J., and Tice, R.R. (1993). Evaluation of a three-exposure mouse bone marrow micronucleus protocol: Results with 49 chemicals. Environ. Mol. Mutagen. 21, 160-179.
89. Shirley, E. (1977). A non-parametric equivalent of Williams’ test for contrasting increasing dose levels of a treatment. Biometrics 33, 386-389.
90. Simmon, V.F., Kauhanen, K., and Tardiff, R.G. (1977). Mutagenic activity of chemicals identified in drinking water. Dev. Toxicol. Environ. Sci. 2, 249-258.
91. Slauter, R.W., and Jeffcoat, A.R. (1989). Metabolism, Disposition and Pharmacokinetics of Cumene in F-344 Rats After Intravenous or Oral Administration or Nose-Only Inhalation (RTI Project Report No. 4353-01F; EPA OTS Fiche No. 0522880). Research Triangle Institute, Research Triangle Park, NC.
92. Slauter, R.W., and Jeffcoat, A.R. (1990). Excretion of Cumene by F-344 Rats Following IV Bolus Administration (RTI Project Report No. 4353-10; EPA OTS Fiche No. 0532647). Research Triangle Institute, Research Triangle Park, NC.
93. Slauter, R.W., and Jeffcoat, A.R. (1992). Identification of an Unknown Urinary Metabolite of Cumene (RTI Project Report No. 4353-20; EPA OTS Fiche No. 0540104). Research Triangle Institute, Research Triangle Park, NC.
94. Straus, D.S. (1981). Somatic mutation, cellular differentiation, and cancer causation. JNCI 67, 233-241.
95. Swenberg, J.A., Short, B., Borghoff, S., Strasser, J., and Charbonneau, M. (1989). The comparative pathology of alpha 2u-globulin nephropathy. Toxicol. Appl. Pharmacol. 97, 35-46.
96. Tarone, R.E. (1975). Tests for trend in life table analysis. Biometrika 62, 679-682.
97. Tegeris, J.S., and Balster R.L. (1994). A comparison of the acute behavioral effects of alkylbenzenes using a functional observational battery in mice. Fundam. Appl. Toxicol. 22, 240-250.
98. Tennant, R.W., Margolin, B.H., Shelby, M.D., Zeiger, E., Haseman, J.K., Spalding, J., Caspary, W., Resnick, M., Stasiewicz, S., Anderson, B., and Minor, R. (1987). Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 236, 933-941.
99. U.S. Environmental Protection Agency (USEPA) (1997). Toxicological Review of Cumene (CAS No. 98-82-8) in Support of Summary Information on the Integrated Risk Information System. Office of Research and Development, U.S. Environmental Protection Agency, Washington, DC.
100. Verschueren, K. (1983). Handbook of Environmental Data on Organic Chemicals, 2nd ed., pp. 779-780. Van Nostrand Reinhold Company, New York.
101. Williams, D.A. (1971). A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics 27, 103-117.
102. Williams, D.A. (1972). The comparison of several dose levels with a zero dose control. Biometrics 28, 519-531.
103. Williams, D.A. (1986). A note on Shirley’s nonparametric test for comparing several dose levels with a zero-dose control. Biometrics 42, 183-186.
104. 1 mice from short-term, prechronic, and chronic studies of the NTP Carcinogenesis Bioassay Program. Environ. Mol. Mutagen. 36, 163-194.
105. Yang, L.L. (1987). CHO/HGPRT Mutation Assay on Cumene (Laboratory Study No. T4786.332010; EPA OTS Fiche No. 0522853). Microbiological Associates, Inc., Bethesda, MD.
106. Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., and Mortelmans, K. (1988). Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environ. Mol. Mutagen. 11 (Suppl. 12), 1-158.
107. Zeiger, E., Haseman, J.K., Shelby, M.D., Margolin, B.H., and Tennant, R.W. (1990). Evaluation of four in vitro genetic toxicity tests for predicting rodent carcinogenicity: Confirmation of earlier results with 41 additional chemicals. Environ. Mol. Mutagen. 16 (Suppl. 18), 1-14.
108. Zeiger, E., Anderson, B., Haworth, S., Lawlor, T., and Mortelmans, K. (1992). Salmonella mutagenicity tests: V. Results from the testing of 311 chemicals. Environ. Mol. Mutagen. 19 (Suppl. 21), 2-141.
109. Abernethy, D.J., Kleymenova, E.V., Rose, J., Recio, L., and Faiola, B. (2004). Human CD34+ hematopoietic progenitor cells are sensitive targets for toxicity induced by 1,4-benzoquinone. Toxicol. Sci. 79, 82-89.
110. Anderson, M.W., Reynolds, S.H., You, M., and Maronpot, R.M. (1992). Role of proto-oncogene activation in carcinogenesis. Environ. Health Perspect. 98, 13-24.
111. Devereux, T.R., Holliday, W., Anna, C., Ress, N., Roycroft, J., and Sills, R.C. (2002). Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years. Carcinogenesis 23, 1737-1743.
112. Ellis, C.A., and Clark, G. (2000). The importance of being K-Ras. Cell. Signal. 12, 425-434.
113. Greenblatt, M.S., Bonnett, W.P., Hollstein, M., and Harris, C.C. (1994). Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878.
114. Gut, I., Nedelcheva, V., Soucek, P., Stopka, P., and Tichavska, B. (1996). Cytochromes p450 in benzene metabolism and involvement of their metabolites and reactive oxygen species in toxicity. Environ. Health Perspect. 104 (Suppl. 6), 1211-1218.
115. Harris, C.C. (1993). p53: At the crossroads of molecular carcinogenesis and risk assessment. Science 262, 1980-1981.
116. Harris, C.C. (1996). p53 tumor suppressor gene: From the basic research laboratory to the clinic—an abridged historical perspective. Carcinogenesis 17, 1187-1198.
117. Hazardous Substances Data Bank (HSDB) (2003). Cumene. National Institute for Occupational Safety and Health, HSDB database available through the National Library of Medicine MEDLARS System.
118. Hegi, M.E., Soderkvist, P., Foley, J.F., Schoonhoven, R., Swenberg, J.A., Kari, F., Maronpot, R., Anderson, M.W., and Wiseman, R.W. (1993). Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice. Carcinogenesis 14, 803-810.
119. Hong, H.H.L., Devereux, T.R., Melnick, R.L., Moomaw, C.R., Boorman, G.A., and Sills, R.C. (2000). Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years. Toxicol. Pathol. 28, 529-534.
120. Hong, H.H., Dunnick, J., Herbert, R., Devereux, T.R., Kim, Y., and Sills, R.C. (2007). Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from Swiss (CD-1) male mice exposed transplacentally to AZT. Environ. Mol. Mutagen. 48, 299-306.
121. Janssen, Y.M., Van Houten, B., Borm, P.J., and Mossman, B.T. (1993). Cell and tissue responses to oxidative damage. Lab. Invest. 69, 261-274.
122. Lambertini, L., Surin, K., Ton, T.V., Clayton, N., Dunnick, J.K., Kim, Y., Hong, H.H., Devereux, T.R., and Sills, R.C. (2005). Analysis of p53 tumor suppressor gene, H-ras protooncogene and profilerating cell nuclear antigen (PCNA) in squamous cell carcinomas of HRA/Skh mice following exposure to 8-methoxypsoralen (8-MOP) and UVA radiation (PUVA therapy). Toxicol. Pathol. 33, 292-299.
123. Le Calvez, F., Mukeria, A., Hunt, J.D., Kelm, O., Hung, R.J., Taniere, P., Brennan, P., Boffetta, P., Zaridze, D.G., and Hainaut, P. (2005). TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: Distinct patterns in never, former, and current smokers. Cancer Res. 65, 5076-5083.
124. Lee, E.W. (1987). Cumene. In Ethel Browning’s Toxicity and Metabolism of Industrial Solvents, 2nd ed. (R. Snyder, Ed.), Vol. 1, Hydrocarbons, Section 1.5. Elsevier Science Publishers, New York.
125. Loeb, L.A. (2001). A mutator phenotype in cancer. Cancer Res. 61, 3230-3239.
126. Maronpot, R.R., Fox, T., Malarkey, D.E., and Goldsworthy, T.L. (1995). Mutations in the ras proto-oncogene: Clues to etiology and molecular pathogenesis of mouse liver tumors. Toxicology 101, 125-156.
127. Meuwissen, R., and Berns, A. (2005). Mouse models for human lung cancer. Genes Dev. 19, 643-664.
128. Osada, H., and Takahashi, T. (2002). Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 21, 7421-7434.
129. Research Triangle Institute (RTI) (1989). Metabolism, Disposition and Pharmacokinetics of Cumene in F344 Rats Following Oral, IV Administration or Nose-Only Inhalation Exposure. RTI/4353-01F. Research Triangle Institute, Research Triangle Park, NC.
130. Reynolds, S.H., Stowers, S.J., Patterson, R.M., Maronpot, R.R., Aaronson, S.A., and Anderson, M.W. (1987). Activated oncogenes in B6C3F1 mouse liver tumors: Implications for risk assessment. Science 237, 1309-1316.
131. Rodenhuis, S., van de Wetering, M.L., Mooi, W.J., Evers, S.G., van Zandwijk, N., and Bos, J.L. (1987). Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. N. Engl. J. Med. 317, 929-935.
132. Rodin, S.N., and Rodin, A.S. (2005). Origins and selection of p53 mutations in lung carcinogenesis. Semin. Cancer Biol. 15, 103-112.
133. Santillo, M., Mondola, P., Seru, R., Annella, T., Cassano, S., Ciullo, I., Tecce, M.F., Iacomino, G., Damiano, S., Cuda, G., Paterno, R., Martignetti, V., Mele, E., Feliciello, A., and Avvedimento, E.V. (2001). Opposing functions of Ki- and Ha-Ras genes in the regulation of redox signals. Curr. Biol. 11, 614-619.
134. Sato, A., and Nakajima, T. (1987). Pharmacokinetics of organic solvent vapors in relation to their toxicity. Scand. J. Work Environ. Health 13, 81-93.
135. Shigenaga, M.K., and Ames, B.N. (1991). Assays for 8-hydroxy-2N-deoxyguanosine: A biomarker of in vivo oxidative DNA damage. Free Radic. Biol. Med. 10, 211-216.
136. Sills, R.C., Hong, H.L., Greenwell, A., Herbert, R.A., Boorman, G.A., and Devereux, T.R. (1995). Increased frequency of K-ras mutations in lung neoplasms from female B6C3F1 mice exposed to ozone for 24 or 30 months. Carcinogenesis 16, 1623-1628.
137. Sills, R.C., Hong, H.L., Melnick, R.L., Boorman, G.A., and Devereux, T.R. (1999). High frequency of codon 61 K-ras A to T transversions in lung and harderian gland neoplasms of B6C3F1 mice exposed to chloroprene (2-chloro-1,3-butadiene) for 2 years, and comparisons with the structurally related chemicals isoprene and 1,3-butadiene. Carcinogenesis 20, 657-662.
138. Sills, R.C., Hong, H.L., Flake, G., Moomaw, C., Clayton, N., Boorman, G.A., Dunnick, J., and Devereux, T.R. (2004). o-Nitrotoluene-induced large intestinal tumors in B6C3F1 mice model human colon cancer in their molecular pathogenesis. Carcinogenesis 25, 605-612.
139. Snyder, R., and Hedli, C.C. (1996). An overview of benzene metabolism. Environ. Health Perspect. 104 (Suppl. 6), 1165-1171.
140. Tam, A.S., Foley, J.F., Devereux, T.R., Maronpot, R.R., and Massey, T.E. (1999). High frequency and heterogenous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors. Cancer Res. 59, 3634-3640.
141. Tchou, J., Kasai, H., Shibutani, S., Chung, M.H., Laval, J., Grollamn, A.P., and Nishimura, S. (1991). 8-Oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity. Proc. Natl. Acad. Sci. U.S.A. 88, 4690-4694.
142. U.S. Environmental Protection Agency (USEPA) (1997). Toxicological Review of Cumene (CAS No. 98-82-8) in Support of Summary Information on the Integrated Risk Information System. Office of Research and Development, U.S. Environmental Protection Agency, Washington, DC.
143. Valentine, J.L., Lee, S.S., Seaton, M.J., Asgharian, B., Farris, G., Corton, J.C., Gonzalez, F.J., and Medinsky, M.A. (1996). Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol. Appl. Pharmacol. 141, 205-213.